Evidence map›Paper›PMID 41116007›Full record

ReviewJournal of cancer education : the official journal of the American Association for Cancer Education2025

The CAIRO Journal Club: A Decade of Impact.

Loay Kassem, Emad Shash, Mohsen Mokhtar, Noha Rashad, Sherin S T Saad, Ahmed M Rabea, Basel Refky, Shaimaa Lasheen, Dalia Medhat, Ahmed H Abdelaziz and 5 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cancer education : the official journal of the American Association for Cancer Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Loay KassemClinical Oncology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Emad ShashMedical Oncology Department, NCI, Cairo University, Cairo, Egypt. emad.shash@nci.cu.edu.eg.ORCID http://orcid.org/0000-0002-2133-9578
Mohsen MokhtarClinical Oncology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Noha RashadDepartment of Clinical Oncology, Faculty of Medicine, Suez University, Suez, Egypt.
Sherin S T SaadClinical Pharmacology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Ahmed M RabeaMedical Oncology Department, NCI, Cairo University, Cairo, Egypt.
Basel RefkySurgical Oncology Department, OCMU, Mansoura University, Mansoura, Egypt.
Shaimaa LasheenClinical Oncology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Dalia MedhatClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Ahmed H AbdelazizClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Hazem El MansyCancer Management and Research Department, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Kyrillus S ShohdySchool of Cancer Sciences and CRUK Scotland Institute, University of Glasgow, Glasgow, UK.
Salem EidMedical Oncology Department, NCI, Cairo University, Cairo, Egypt.
Khaled A KamalClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Amr ShafikClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decade, the CAIRO Journal Club (CJC) has evolved into a cornerstone of oncology education and multidisciplinary collaboration across Egypt and the broader Middle East and North Africa (MENA) region. This narrative review charts CJC's formative journey, analyzes its educational impact, and outlines forward-looking strategies to further democratize high-quality cancer care. Since 2013, CJC has convened more than 120 interactive events under the Egyptian Foundation of Medical Sciences (EFMS) umbrella, supplemented by masterclasses, simulation-based forums, and hands-on workshops that prioritize breast, thoracic, gastrointestinal, and genitourinary malignancies. A deliberate emphasis on evidence-based, resource-adapted protocols underpins these activities, fostering context-appropriate decision-making through case-linked learning and live audience polling. Independent assessments and post-event surveys demonstrate significant gains in participants' knowledge retention, clinical confidence, and treatment-planning skills, particularly among practitioners in peripheral or resource-constrained settings. Moreover, CJC's digital extensions (including livestreamed symposia and moderated social-media discussion boards) have expanded its national footprint, yielding > 30,000 cumulative virtual attendances (unique live logins and on-demand viewers from 2019-2024) and markedly lowering geographic access barriers. Building on this momentum, CJC will launch international virtual tumor boards with partners in Egypt, North Africa, the Levant, the Gulf, and globally; establish structured mentoring for early-career oncologists and allied professionals across the region; introduce AI-enabled adaptive learning modules; and develop accredited postgraduate certificate programs aligned with WHO competency frameworks. Future evaluation will also examine educational and practice impact, with a focus on expanding training, mentoring, and scholarly outputs. CJC's experience illustrates how a regional, volunteer-driven initiative can bridge oncology-education disparities through blended, scalable learning models. Its planned innovations offer a replicable blueprint for other LMIC contexts seeking to strengthen cancer-care capacity through sustained professional development and digital inclusion.

Indexed as

CAIRO Journal ClubCancerCancer EducationEFMSLow-Middle-Income Countries

Identifiers

PMID41116007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.